KEAP1/NRF2

Class

KEAP1/NRF2 pathway activator

KEAP1 (Kelch-like ECH-associated protein 1) and NRF2 (nuclear factor erythroid 2-related factor 2) form a cellular sensor system for oxidative and electrophilic stress. Under normal conditions, KEAP1 continuously binds NRF2 and directs it to a protein-degradation complex, keeping NRF2 levels low. When cells encounter oxidative damage, chemical modification of KEAP1 releases NRF2, which then moves into the nucleus and switches on a broad set of genes encoding antioxidant enzymes, detoxification proteins, and other cytoprotective factors. This pathway is a central defense mechanism against cellular stress, and its pharmacological activation is of interest wherever tissue is damaged by oxidative or inflammatory processes, including chronic kidney disease, certain metabolic and neurodegenerative conditions, and inflammatory disorders. By artificially triggering the same release of NRF2 that stress would normally cause, small-molecule activators aim to boost the body's own protective gene program before or during ongoing tissue injury. Because this pathway governs a wide network of downstream genes rather than a single protein, its activation can have broad, systemic protective effects, but also carries the possibility of unintended consequences given NRF2's role in regulating cell survival pathways more generally.